BIO-TECHNE Corp (TECH)
Bio-Techne Corp. is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. It operates through the Protein Sciences, and Diagnostics and Genomics segments. The Protein Sciences segment develops and manufactures purified proteins, and reagent solutions. The Diagnostics and Genomics segment develops and manufactures diagnostic products. The company was founded in 1976 and is headquartered in Minneapolis, MN.
Address
614 MCKINLEY PL N E
MINNEAPOLIS, MN 55413
Founded
1976
Number of Employees
3,100
Website
http://www.bio-techne.com
Buyback
Buyback Data | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
---|---|---|---|---|---|---|---|---|---|---|---|---|
$ Amount Purchased ($ in 000s ) |
- | - | - | - | - | - | - | $41,293 | - | $80,047 | - | $60,670 |
Average Price | - | - | - | - | - | - | - | $115.68 | - | $57.28 | - | $69.16 |
# Shares Purchased | - | - | - | - | - | - | - | 356,952 | - | 1,397,471 | - | 877,212 |
Buyback Performance | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Return to Date | - | - | - | - | - | - | - | -36.0% | - | 29.2% | - | 7.0% |
S&P 500 Return to Date | - | - | - | - | - | - | - | 31.7% | - | 31.3% | - | 31.5% |
Excess Total Return | - | - | - | - | - | - | - | -67.7% | - | -2.1% | - | -24.5% |
Quartile Rank |
|
|
|
|
|
|
|
|
|
|
|
|
Percentile Rank | - | - | - | - | - | - | - | 20% | - | 69% | - | 47% |
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)